Live: Arista Networks Is Reporting Q1 Earnings. Can $ANET Continue Its 32% YTD Rally?

Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Chris Lange | Mar 25, 2017 at 9:15 AM EDT

How Health Care Stocks Responded to the Shelved Health Care Bill

24/7 Wall St. has taken a look at a few companies within the health care sector that might have seen…

Chris Lange | Mar 23, 2017 at 1:35 PM EDT

2 Health Care Stocks Crushed on Thursday

Should Trump’s new health care bill pass, investors might gain confidence that the president can actually push his agenda, while…

Chris Lange | Mar 23, 2017 at 10:05 AM EDT

How a Key European Decision Is Making All the Difference at HTG

HTG Molecular Diagnostics saw its shares make a massive move to the upside after the company announced that it has…

Chris Lange | Mar 22, 2017 at 8:50 AM EDT

Regenxbio Sinks After Announcing Secondary Offering

Regenxbio plans to offer more than 3 million shares of common stock in a secondary offering valued up to more…

Chris Lange | Mar 21, 2017 at 12:40 PM EDT

Why Pulmatrix Investors Are Breathing a Sigh of Relief

Pulmatrix saw its shares take a massive jump on Tuesday after the company announced that it received a crucial patent…

Lee Jackson | Mar 21, 2017 at 10:25 AM EDT

5 Biotech Stocks That Could Skyrocket From Upcoming Catalysts

A new SunTrust Robinson Humphrey research report focuses in on biotech companies that have upcoming clinical data that could prove…

Chris Lange | Mar 20, 2017 at 10:55 AM EDT

Monday’s Top Biopharma Movers

Esperion Therapeutics and a few other biopharma stocks made massive runs on Monday morning.

Lee Jackson | Mar 20, 2017 at 9:50 AM EDT

Jefferies Has 4 Red-Hot Biotech and Pharmaceutical Stocks to Buy Now

These are four top stocks to buy in a sector that has much more value than many on Wall Street.…

Chris Lange | Mar 15, 2017 at 12:10 PM EDT

Wednesday’s Biggest Biopharma Movers

The broad markets are inching forward on Wednesday after hitting new highs in what has been known as the Trump…

Chris Lange | Mar 15, 2017 at 9:45 AM EDT

Is Valeant Finished Now That Ackman Is Out of the Picture?

Valeant Pharmaceuticals shares hit a multiyear low on Tuesday after it was announced that Bill Ackman would be selling off…

Chris Lange | Mar 13, 2017 at 10:35 AM EDT

What a Combined Gilead and Incyte Would Look Like

Gilead Sciences has long been in need of a catalyst to move its business, and a lot of investors and…

Douglas A. McIntyre | Mar 11, 2017 at 8:40 AM EST

Prescription Drug Misuse Hits 70% of American Workplaces

Prescription drug misuse has spread so much that it is a problem in over 70% of American workplaces, according a…

Chris Lange | Mar 6, 2017 at 3:45 PM EST

Why One Key Analyst Believes That Valeant Is Kicking the Can in Its Restructuring Deal

Valeant Pharmaceuticals announced that it intends to refinance some of its debt. One key analyst thinks that this might be…

Chris Lange | Mar 6, 2017 at 1:45 PM EST

Monday’s Top Health Care Stocks Screaming Higher

Markets may be slowing down and taking a step back after hitting new highs in what has been known as…

Lee Jackson | Mar 6, 2017 at 10:20 AM EST

Red-Hot Biotech Companies Highlight Jefferies Top Stocks to Buy

In this week's top stock picks from Jefferies, three very prominent biotechnology stocks are featured, including one that is a…

1 … 171 172 173 174 175 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

How Health Care Stocks Responded to the Shelved Health Care Bill

2 Health Care Stocks Crushed on Thursday

How a Key European Decision Is Making All the Difference at HTG

Regenxbio Sinks After Announcing Secondary Offering

Why Pulmatrix Investors Are Breathing a Sigh of Relief

5 Biotech Stocks That Could Skyrocket From Upcoming Catalysts

Monday’s Top Biopharma Movers

Jefferies Has 4 Red-Hot Biotech and Pharmaceutical Stocks to Buy Now

Wednesday’s Biggest Biopharma Movers

Is Valeant Finished Now That Ackman Is Out of the Picture?

What a Combined Gilead and Incyte Would Look Like

Prescription Drug Misuse Hits 70% of American Workplaces

Why One Key Analyst Believes That Valeant Is Kicking the Can in Its Restructuring Deal

Monday’s Top Health Care Stocks Screaming Higher

Red-Hot Biotech Companies Highlight Jefferies Top Stocks to Buy

Live: Arista Networks Is Reporting Q1 Earnings. Can $ANET Continue Its 32% YTD Rally?

Live: Navitas Semiconductor Q1 Earnings Tonight. Can the 676% Surge Survive the Print?

Live: AMD Reports Q1 Earnings Tonight. Will the Stock Continue Its 255% 1-Year Explosion?

Which Big-Box Store Chain Has Dominated 2026: Walmart, Target, or Costco?

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

Jim Cramer Isn’t a Fan of Microsoft After Rough Quarter. Is He Right to Be Skeptical?

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

27% of Americans Own ETFs but Allocate Just 6%, Here's Why That Costs Them Retirement Income

Live: Navitas Semiconductor Q1 Earnings Tonight. Can the 676% Surge Survive the Print?

Which Big-Box Store Chain Has Dominated 2026: Walmart, Target, or Costco?

Health and Healthcare Articles

All Health and Healthcare Articles

How Health Care Stocks Responded to the Shelved Health Care Bill

2 Health Care Stocks Crushed on Thursday

How a Key European Decision Is Making All the Difference at HTG

Regenxbio Sinks After Announcing Secondary Offering

Why Pulmatrix Investors Are Breathing a Sigh of Relief

5 Biotech Stocks That Could Skyrocket From Upcoming Catalysts

Monday’s Top Biopharma Movers

Jefferies Has 4 Red-Hot Biotech and Pharmaceutical Stocks to Buy Now

Wednesday’s Biggest Biopharma Movers

Is Valeant Finished Now That Ackman Is Out of the Picture?

What a Combined Gilead and Incyte Would Look Like

Prescription Drug Misuse Hits 70% of American Workplaces

Why One Key Analyst Believes That Valeant Is Kicking the Can in Its Restructuring Deal

Monday’s Top Health Care Stocks Screaming Higher

Red-Hot Biotech Companies Highlight Jefferies Top Stocks to Buy

Live: Arista Networks Is Reporting Q1 Earnings. Can $ANET Continue Its 32% YTD Rally?

Live: Navitas Semiconductor Q1 Earnings Tonight. Can the 676% Surge Survive the Print?

Live: AMD Reports Q1 Earnings Tonight. Will the Stock Continue Its 255% 1-Year Explosion?

Which Big-Box Store Chain Has Dominated 2026: Walmart, Target, or Costco?

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

Jim Cramer Isn’t a Fan of Microsoft After Rough Quarter. Is He Right to Be Skeptical?

Featured Reads

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

27% of Americans Own ETFs but Allocate Just 6%, Here's Why That Costs Them Retirement Income